Overview of MGD and Its Causes

Opinion
Video

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide an overview of meibomian gland dysfunction (MGD) and its causes.

Video content above is prompted by the following questions:

  • How is dry eye different than meibomian gland dysfunction (MGD)? What causes MGD?
Recent Videos
Diabetic eye care expert A. Paul Chous, OD, MA, FAAO, shares insights on patient care and research
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Megan Cavet, PhD
Related Content
Dry eye graphic Image credit: ©krissikunterbunt - adobe.stock.com

That’s some nerve! Ocular drug delivery and dry eye

Katherine M. Mastrota, MS, OD, FAAO, Dipl ABO
October 14th 2024
Article
Split image of dry eye before and after treatment Image credit: ©Alessandro Grandini - adobe.stock.com

Optometrists, organizations provide insight for State of Dry Eye survey

Jordana Joy, Associate Editor;Jessilin Quint, OD, MBA, MS, FAAO;Grace Koennecke
August 16th 2024
Podcast
Eye split into graphic of healthy and irritated Image credit: AdobeStock/AlessandroGrandini

Aldeyra Therapeutics resubmits NDA for reproxalap for DED signs and symptoms treatment

Jordana Joy, Associate Editor
October 3rd 2024
Article
Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

Ken DauSchmidt;Brooke Henson, Editor
September 24th 2021
Podcast
Contact lens on finger Image credit: AdobeStock/megaflopp

Inside the overlap between scleral lenses and dry eye

Julie Song, OD, FAAO, FSLS
September 24th 2024
Article
Black and white FDA sign on wall Image credit: ©maurice norbert - adobe.stock.com

FDA confirms acceptability of remaining Phase 3 pivotal clinical trials for Palatin's PL9643 in DED

David Hutton, Managing Editor, Ophthalmology Times
September 10th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.